BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Saturday, June 20, 2026
Breaking News: Viva in vivo! At EHA, in vivo CAR T data continues to impressBreaking News: Ongoing coverage of the Ebola outbreak
Home » Topics » BioWorld Asia

BioWorld Asia
BioWorld Asia RSS Feed RSS

Holiday notice

July 6, 2021
BioWorld's offices were closed in observance of Independence Day in the U.S. No issue was published Monday, July 5.
Read More

Regulatory actions for June 29-July 2, 2021

July 6, 2021
Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific, including: Biontech, Chugai, Direct Biologics, Genentech, HDT, Hutchmed, Ildong, Innocare, Innovent, Junshi, Lupin, Moderna, Pfizer, Roche, Solasia, Yiling.
Read More

In the clinic for June 29-July 2, 2021

July 6, 2021
Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications, including: ABL, Altimmune, Angion Biomedica, Astrazeneca, Atea, Bionet Asia, Biophytis, Brim, Codagenix, Curevac, Cynata, Ildong, I-Mab, LG Chem Life Sciences, Moderna, Neurophth, Nippon Shinyaku, Novavax, Pfizer, Pharmajet, RDIF, Rigel, Roche, Sinovac, Technovalia, VBI Vaccines.
Read More

Other news to note for July 6, 2021

July 6, 2021
Biopharma happenings in Asia-Pacific, such as deals and partnerships, grants, preclinical data and other news in brief, including: Aditum, Amyris, Ancora, Astrazeneca, Biophytis, Clover, Codagenix, Dynavax Technologies, Endo International, Glaxosmithkline, Nant Africa, Oyster Point, PYC, Quanta, Simcere, Taisho, TLC, Vir, Vivoryon.
Read More
DNA, dollars illustration

Sirnaomics closes $105M series E to advance polypeptide nanoparticle-based siRNA therapeutics in multiple cancers

July 6, 2021
By Elise Mak
Just five days after raising $105 million in a series E financing round, RNA interference therapeutics specialist Sirnaomics Inc. obtained another IND approval from the FDA for its dual-targeting small interfering RNA (siRNA) inhibitor STP-707 to start a basket study in oncology. Sirnaomics’ CEO Patrick Lu told BioWorld in an exclusive interview that an I.V. administration of STP-707 will be tested to tackle solid cancers that may have metastasized into other potential areas or tissue types in the body.
Read More

Financings for July 6, 2021

July 6, 2021
Biopharmas in Asia-Pacific raising money in public or private financings, including: Oncusp, Vaxthera.
Read More

Appointments and advancements for July 6, 2021

July 6, 2021
New hires and promotions in the biopharma industry in Asia-Pacific, including: Immunoscape, Takeda.
Read More

Conference data for June 28, 2021: ADA

June 29, 2021
Data presented at the 81st Scientific Sessions of the American Diabetes Association, including: Beijing Cosci-Remd, Remd Biotherapeutics, Scohia.
Read More

Conference data for June 23, 2021: EASL

June 29, 2021
Data presented at The International Liver Congress – The Annual Meeting of the European Association for the Study of the Liver, including: Brii Biosciences, VBI Vaccines.
Read More

Regulatory actions for June 22-28, 2021

June 29, 2021
Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific, including: Alterity, Amgen, Astellas, Astrazeneca, Beigene, Biogen, Bioheng, Eisai, Fibrogen, Hutchison China Meditech, Hutchmed, Huyabio, I-Mab, Innocare, Kite, Lynk, Medicenna, Medolife Rx, Merck, Merz, Poxel, Prestige, PTC, RDIF, Resolve, Samsung Bioepis, Sanotize Research and Development, Santen, Senhwa, Shanghai Fosun, Shenzhen Chipscreen, Sumitomo Dainippon, Teijin, Teva.
Read More
Previous 1 2 … 335 336 337 338 339 340 341 342 343 … 1489 1490 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for June 18, 2026.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for June 16, 2026
  • Brain with puzzle piece removed

    Gene replacement rescues autism-related phenotypes in mice

    BioWorld Science
    Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...
  • Red blood cells, DNA

    For clonal hematopoiesis, epigenetics can be in driver’s seat

    BioWorld Science
    Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
  • Illustration of amyloid plaques in Alzheimer's disease

    Elixiron’s enrupatinib shows upbeat interim phase II AD results

    BioWorld
    Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing